Pharmafile Logo
Pharmafocus logo
Advanced Search

Dr Stephen Rosevear joins Cogent as director of Research & Policy

February 7, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cogent, Stephen Rosevear

Prior to joining Cogent, Stephen was HMRC’s chief analyst on the corporate real estate market, undertaking tax modeling and policy development for …

Appointment

GSK earmarks $60m for Australian plant

February 7, 2012

News

US bill tries to tackle medicine shortages

February 7, 2012

News

Marchesini buys PRB to get bigger in pharma packaging

February 7, 2012

News

Miliband: We have three months to save the NHS

February 7, 2012

News

Merck KGaA buys into promising cancer med

February 7, 2012

News

NICE to review local formularies

February 6, 2012

News

PM Society unveils new look

February 3, 2012

News

Succinct to join OPEN Health

February 3, 2012

News

GP group mounts full opposition to health reforms

February 3, 2012

News

Roche rounds off year with solid performance

February 3, 2012
Sales and Marketing Roche

A strong performance in its diagnostics division was among the factors enabling Roche to deliver a solid set of results …

News

Andrew Morgan joins Republic M!

February 2, 2012
Business Services, Medical Communications, Sales and Marketing Andrew Morgan, Republic M!

Republic M! has strengthened its team with the appointment of Andrew Morgan as head of operations. Andrew has leadership expertise …

Appointment
Merck image

Merck posts strong results for 2011

February 2, 2012
Sales and Marketing Frazier, Merck, Singulair, Victrelis

Foreign exchange rates and strong sales from established products helped Merck to achieve single-digit growth for 2011.  The US firm …

News

Working Life: Carlos Gallardo, general manager, Almirall

February 2, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Carlos Gallardo

BiographyCarlos Gallardo is general manager of the Almirall UK and Ireland affiliate from its creation in 2008. He has an …

Feature
AstraZeneca picture

AstraZeneca to cut 7,300 jobs as growth stalls

February 2, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AZ, AstraZeneca, David Brennan, R&D

AstraZeneca will make 7,300 cuts to its sales and R&D staff by 2014, but the company has not yet said …

News
Pfizer picture

Pfizer recalls oral contraceptive for packaging errors

February 2, 2012
Manufacturing and Production Akrimax, Bedford, Cephalon, Lo/Ovral-28, Pfizer, Teva

Pfizer has been forced to recall a large volume of oral contraceptive packs distributed in the US market because a …

News
Zytiga image

Zytiga cost too high, says NICE

February 2, 2012
Sales and Marketing NICE, Zytiga

NICE is not recommending Janssen’s prostate cancer pill Zytiga because of its high cost. Zytiga (abiraterone) is not recommended, in …

News

RSA announces promotions

February 2, 2012
Medical Communications, Sales and Marketing rsa

Life sciences executive search and interim management specialist firm RSA, has announced its latest promotions.John Callagher (pictured) has been promoted …

Appointment

Sigma-Aldrich acquires testing company BioReliance

February 1, 2012
Research and Development Sigma-Aldrich

Sigma-Aldrich has acquired clinical testing company BioReliance for $350 million. Purchased from Avista Capital Partners, BioReliance provides services that include …

News

Pfizer weathers patent expiry storm

February 1, 2012

Pfizer has managed to keep its head above water in its full year results, but faces a tough 2012 without …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026